{"status": "Ok", "redirect_url": "https://investors.arcusbio.com/investors-and-media/press-releases/press-release-details/2026/Arcus-Biosciences-Announces-Clinical-Trial-Collaboration-and-Supply-Agreement-to-Evaluate-Casdatifan-in-Combination-with-PDL1VEGFA-Bispecific-Immunomodulator-to-Treat-Kidney-Cancer/default.aspx", "message": "News view counter 777167 successfully enlarged"}